New. The AMR Exchange – Global Voices, Shared Solutions. Ep. 1: Meet Fleming Fund Fellows + Prof. Till Bachmann on tackling AMR through One Health. open.spotify.com/episode/0Yfb... @bachmanntill.bsky.social

Thanks so much to everyone who joined the workshop on transdisciplinary #AMR research @edfuturesinstitute.bsky.social - really rich and fruitful discussions from engineering and plants, to diagnostics and policy 🧪🧫 @bachmanntill.bsky.social

Global action on AMR. In Feb 2025, Uganda’s Harriet Akello met Till Bachmann @bachmanntill.bsky.social at the AMR Conf. in Switzerland merging frontline insights with global expertise. True progress needs local context and global collaboration. #AMR #GlobalHealth #OneHealth #StopSuperbugs

Now it’s @drneilstone.bsky.social talking about social media and medicine. “Bluesky is the dominant platform now.” He said it. We will get him over to Bluesky for good! 💪🏼😉😁 #ESCMIDGlobal #IDSky #MedSky

Agree, still needs a lot of fixes but will keep going. It is worth it!

The congress may be ending today but the content can be revisited in our #ESCMIDGlobal replay section. All scientific sessions can be watched or rewatched on the virtual congress platform available for 6 months: ow.ly/f6fP50VzPeU

Honest reflection: ESCMID 2025 felt quieter online this year—fewer posts, threads, and live updates. Why the shift? – Scattered hashtags – X/Bluesky split – Time zone mismatch – Less live posting – Conference fatigue? Did others notice it too? #ESCMIDGlobal #IDSky

The essence of prevention if anticipating and investing - well said Cornelis Boersma to conclude the #PipelineMonday #ESCMIDGlobal 2025 at session ‘#HTA of innovations in infectious diseases’ with Claudia Wild, Maarten Postma, Koen Pouwels @escmid.bsky.social @ox.ac.uk @unigroningen.bsky.social

In #bloodstreaminfections direct-from-blood detection is the holy grail. Fantastic talks with ultrarapid, single cell AST, integrated sample to result and critical review. Thx to co-chair Robin Patel @mayoclinic.org and Hyelyn Joo, Johan Elf, Kim Chapin, Anna Peri @escmid.bsky.social #ESCMIDGlobal

Prevention is key in the fight against #AMR. Tremendous session at Vaccines Pipeline Corner #ESCMIDGlobal 2025 chaired by @ccvernhes.bsky.social with Pedro Madureira #Immunethep Ana IR Rosado #Vaxdyn Lyudmila Kovalchuke #Baxerna Hanna Bobrovsky #LimmaTech @ihieurope.bsky.social @escmid.bsky.social

Full house at Diagnostics Pipeline Corner #ESCMIDGlobal 2025 for host, pathogenID, rapid AST, academic start-up to field trials pathway. Great tech, talks and discussion. Thx Iain Miller #PresymptomHealth Liza Löf #Readily Aleksandre Japaridze #SoundCell Paul Docherty #ProtonDx @escmid.bsky.social

Thanks a lot @valeriagigante.bsky.social for a wonderful opening talk! See here for WHO’s reports on antifungal drugs and diagnostics for fungal priority pathogens www.who.int/news/item/01...

Just made a custom feed that pulls in a wide array of hashtags being used at ESCMID Global 2025 May have a few minutes delay, but contains posts with #ESCMIDGlobal #ESCMIDGlobal2025 #ESCMID2025 #ECCMID2025 Feel free to pin it to your timelines. Hope it's helpful #IDSky bsky.app/profile/did:...

the #PipelineMonday is progressing well this afternoon. See my interview about background and plans for the track at #ESCMID TV m.youtube.com/watch?v=U9WX... @escmid.bsky.social

Indeed a beautiful day to talk about the future! ☀️

excellent attendance and interest at the early morning session of #PipelineMonday!!

Need to get balance right between tech innovation and capacity and infrastructure building to ensure timely uptake and utilisation, Alexandra Cameron. Have a look at the recent WHO Fungal diagnostics landscape report, I had the pleasure to contribute. @who.int @escmid.bsky.social #PipelineMonday

Looking for the #PipelineMonday? Go along the light long corridor where the sun shines to find the presentations and discussions on innovation. Two sessions in their full swing with a full house!! Hall 12 and Arena 4 #ESCMIDGlobal 2025 @escmid.bsky.social

A lot is to be done to enhance uptake of fungal #diagnostics. Innovation in technology but also guidelines and regulation. Fully agree with Milena Sinigaglia and JT Harrison #PipelineCorner #PipelineMonday #ESCMIDGlobal 2025 @escmid.bsky.social

Fungal #PipelineCorner is packed in the great Arena setting #ESCMIDGlobal 2025 @escmid.bsky.social discussing pipeline and innovation in fungal therapeutics and diagnostics. Interest in #PipelineMonday is great

great discussion and comments to start a day full of dialogue and exchange. Thanks Ursula Theuretzbacher and John Rex

'Progress and challenges in drug discovery and development' kicks off in Hall 12 with a magnificent line up of speakers @escmid.bsky.social and Valeria Gigante @who.int having the first talk in the inaugural session of the new #PipelineMonday #ESCMIDGlobal 2025 @escmid.bsky.social

Good morning #ESCMIDGlobal 2025! Today is the day - Pipeline Monday!! Packed programme at Hall 12 - 8:30 Therapeutics 11:00 AMR & Vaccines 13:30 Clin Decision Support Sys 14:55 New Abx yes/no? 16.15 BSI Dx Arena 4 - 9:30 Fungal 11:00 Dx 13:30 Bioinf 14:45 Vacc 16:15 Rx 17:30 HTA @escmid.bsky.social

Great presentation of #ESCMIDGlobal Diagnostic Pipeline Corner veteran Esme Iseri of #Utilizer showing plans to go for rapid AST with their 'digital dipslide' for #UTI. Incubator needed, 8h, 36C. Good discussion on temp variation impact. #AMR #POCT #ESCMIDGlobal 2025 @escmid.bsky.social

Marit Bot used Rapid ESBL NP and ResistanceFinder tests directly on UTI samples. Interesting data, cloudiness of urine impacted on readout and discrepancies found. Will go on for further validation. #AMR #POCT #ESCMIDGlobal 2025 @escmid.bsky.social

'For detection bacterja at POCT we basically have nothing (except Streptest)' Patrice Nordman presenting susceptibility test (Rapid AmpNP) for bla for UTI based on nitrocefin. Done on 10^3 CFU/mL and more. Need centrifige. 30 -120min. 15-20 EUR. #AMR #POCT #ESCMIDGlobal 2025

Christian Moguet of NG Biotech on a LFT for DHA type enzynes (plasmid and chrom). Showed dependency test line intensity from expression level. Will need a reader for quantification. CMY is coming next. Will cover other enzymes to achieve utility #AMR #POCT #ESCMIDGlobal 2025 @escmid.bsky.social

Interesting opening talk by Julia Rogers of ga Diagnostics on lateral flow test for #KPC from lower repiratory infections. LOD not determined yet but tested with 'extraction from sputum using liquefying agents' without culture. #AMR #POCT #RTI #ESCMIDGlobal @escmid.bsky.social

Good morning everyone at #ESCMIDGlobal 2025 On to another exciting productive day in Vienna. Have a wonderful Sunday @escmid.bsky.social

Fantastic to see so many of the wonderful Edinburgh Fleming Fund Fellows at #ESCMIDGlobal @escmid.bsky.social for a face to face connection to Heidi Hopkins @mottmacdonald.bsky.social and Maneesh Paul after they saw him online at our recent #AMR Forum seminar @uoe-eid.bsky.social

Many many congratulations to the ESCMID awardees!

What a wonderful session on use of #diagnostics in the #community! Lots of evidence for positive impact but also barriers for utilisation and need for training. Thanks to the chairs Heiman Wertheim and Sonja Lewycka and speakes #ESCMIDGlobal 2025 @heiman-wertheim.bsky.social @escmid.bsky.social

Great final talk in the session of Yoel Lubell of #MORU on cost effectiveness of #CRP #POCT. A lot to be learned from #malaria #RDTs. A new multiplex biomarker test to differentiate viral and bacterial infection is coming soon. Read the take home messages. #ESCMIDGlobal 2025 @escmid.bsky.social

Wonderful talk of @helenzambart.bsky.social on #CRP testing in diagnosing #TB in #Zambia. CRP does not distinguish TB from other infections but may have a value in TB/Lung sceening. Note that #POCT needed to be moved out of high temperature environment. #ESCMIDGlobal 2025 @escmid.bsky.social

Testing for #CRP in community pharmacies. Staff stopped using test after initial results all showed that no antibiotic was needed. Thought tests not working and feared loss of Abx revenues. Allowed to charge 1USD and training helped to reverse this. A. Onwunduba #ESCMIDGlobal @escmid.bsky.social

Powerful case for point of care testing of #CRP in primary care and #pharmacies to avoid unnecessary #antibiotic use. Sensitisation of healthcare workers and patients is required to ensure uptake. Thi Thuy Nga Do of #OUCRU #POCT #AMR #ESCMIDGlobal 2025 @escmid.bsky.social

Great talk by Stefania Stefani of Univ of Catania on surveillance and sequencing to enhance awareness of local #epidemiology, #resistamce #virulence #genomes, 'when NDM entered we could immediately respond' but 'we must not confuse colonization and infection' #ESCMIDGlobal 2025 @escmid.bsky.social

Just finished my interview with the fantastic Judith Cohen at #ESCMID 2025 TV on the inaugural #PipelineMonday. Come along for exciting sessions on the latest innovation and translational perspectives in #AMR #vaccines #diagnostics #therapeutics #data and health #economics @escmid.bsky.social

The next Global Action Plan on Antimicrobial Resistance is coming, the update is underway. Expect a survey in the coming weeks. Jean-Pierre Nyemazi #Quadripartite @who.int @fao.org @unep.org #WOAH #ESCMIDGlobal @escmid.bsky.social #AMR

Crucial question to panel by Holger Rhode: What are the most pressing data gaps for policy makers to make decision on AMR interventions? Make best use of #IPC, #WASH, #AMU, #AMR #surveillance, refined cause of death assignmt incl #AMR, connect across #OneHealth etc. @escmid.bsky.social #ESCMIDGlobal

Important inclusion of #OneHealth perspectice at the Science Policy Forum #UNGA #AMR #ESCMIDGlobal 2025 by Junxia Song @fao.org outlining surveillance in the agrifood sector. Crosslinking with other OneHealth AMR domains needed #OHAMR #JPIAMR @escmid.bsky.social @icarsglobal.bsky.social

Tochi Okwor of Nigeria Center for Disease Control on #AMR National Action Plan implementation on local level 'Science needS to be the North Star' - well said! #ESCMIDGlobal 2025 @escmid.bsky.social #UNGA

Excellent talk by @hutiny.bsky.social highlighting the complexity and need to take a data driven, results-based and people centred approach plus 'increase the coverage of #vaccines and #diagnostics' for 10% #AMR mortality reduction by 2030 #ESCMIDGlobal @escmid.bsky.social @who.int

Just arrived at #ESCMIDGlobal 2025 straight into the Science Policy Session for an excellent start. Lets get Bluesky buzzing! See you around and at the #PipelineMonday #AMR @escmid.bsky.social @uoe-eid.bsky.social

Join us later today in Hall 4 from 15:00-16:45 CEST for the opening session of the #AMR Science-Policy Forum at #ESCMIDGlobal 2025! Take the opportunity to explore how science can inform policy and the implementation of UNGA targets on AMR. #IDSky #clinmicro

Very pleased to see @who.int publishing its very first reports on tests and treatments for #fungal #infections - and the contributions made by @bachmanntill.bsky.social, EID AMR Strategy lead. edinburgh-infectious-diseases.ed.ac.uk/news-and-eve... @allshire-lab.bsky.social @bethmills.bsky.social

The new film on DOSA is out describing our exciting journey to develop #diagnostics for urinary tract infections in rural communities in India. www.youtube.com/watch?v=H4zG... #AMR #POCT #LMICs @edinuni-irr.bsky.social @uoe-eid.bsky.social @unioftheartslondon.bsky.social @iitdelhi.bsky.social

🔬 AMR Forum Lecture 🔬 Join the AMR Forum on Friday 21 March for a special lecture with Dr Maneesh Paul from Microvioma. Hosted by @bachmanntill.bsky.social, this promises to be a super talk! Register ASAP as spaces are limited ➡️ inventing-anti-infectives.eventbrite.co.uk

It has been wonderful to see the #FlemingFund fellows from Uganda visiting their counterparts in Zambia, forging connections across the region, as together they seek effective ways to comabt #antimicrobialresistance edinburgh-infectious-diseases.ed.ac.uk/connection-p... @bachmanntill.bsky.social